Global High-Priority Regulatory Events — October 13, 2026

13-10-2026

Mehai Technology Limited has entered into a Share Purchase Agreement dated 12 October 2026 to acquire 100% of the equity share capital of Hi-Tech Services Private Limited, an unlisted IT-enabled data processing services company, for a total cash consideration of ₹4,50,00,000 (Rupees Four Crore Fifty Lakh). The target reported nil turnover for FY 2023-24, FY 2024-25 and FY 2025-26, so the deal is an early-stage expansion into data processing and ITeS rather than an acquisition of an operating revenue base. Completion is subject to conditions precedent and share transfer formalities, with no governmental or regulatory approvals required.

• · Target company CIN U72300WB1984PTC037826, registered office at Uniworld City, New Town, West Bengal
• · Transaction is not a related-party transaction and promoter/group companies have no interest in the target
• · Consideration is in cash under the Share Purchase Agreement dated 12 October 2026
• · Implied price of roughly ₹16,060 per share (₹4.5 Cr over 28,030 shares) versus ₹10 face value, a significant premium despite nil turnover
• · Company will intimate the exchange on completion of the acquisition

13-10-2026

Park Dental Partners, Inc. (PARK) disclosed under Item 1.05 that unauthorized access to its computer network, first identified on August 28, 2026, resulted in unauthorized acquisition of data including protected health information for impacted patients, with notifications underway under state and federal law. Four putative class actions have been filed in Ramsey County, Minnesota state court, the first on September 3, 2026, and plaintiffs moved on October 7, 2026 to consolidate them and appoint interim lead class counsel. The company states it has identified no material impact on its financial condition or results of operations to date, including expected legal and advisor costs, and is not aware of any unauthorized use of PHI or resulting damages.

• · Company engaged external cybersecurity experts and forensic specialists and notified law enforcement after identifying the intrusion
• · Lawsuits allege negligence, negligence per se, invasion of privacy, breach of fiduciary duty, unjust enrichment, breach of implied contract, and breach of confidence, and also allege untimely notification to affected individuals
• · Company intends to vigorously defend the litigation and anticipates regulatory responses
• · Cases are docketed as 62-CV-26-6341, 62-CV-26-6381, 62-CV-26-6384, and 62-CV-26-7111 in the Second Judicial District, Ramsey County

13-10-2026

LogicMark, Inc. filed an 8-K on 2026-10-13 (AccNo 0001213900-26-109112) reporting completion of an acquisition or disposition of assets (Item 2.01), a material modification to security holder rights (Item 3.03), a change in control of the registrant (Item 5.01), director/officer departures or compensatory arrangements (Item 5.02), and bylaw/articles amendments (Item 5.03). The filing text provided is limited to item headers; no deal terms, counterparties, consideration, or financial figures are disclosed in the supplied summary. Sentiment cannot be assessed beyond the event categories themselves.

• · Filing is an 8-K of approximately 6 MB containing six items: 2.01, 3.03, 5.01, 5.02, 5.03, 9.01
• · Item 5.01 indicates a change in control, a more significant signal than a standard acquisition completion

13-10-2026

CID HoldCo, Inc. (doing business as Dot Ai, Nasdaq: DAIC) completed the acquisition of Envoy Technologies, Inc. from BladeRanger Ltd. in an all-stock transaction valued at approximately $65 million at a $6.00 per share reference price. The deal adds an established, revenue-generating EV carsharing business, but the filing states the company is seeking to satisfy Nasdaq's $2.5 million stockholders' equity requirement, which remains subject to Nasdaq Hearings Panel confirmation. Following the planned conversions of the Series C Preferred Stock and Envoy's $12.5 million convertible note, BladeRanger is expected to hold a majority of Dot Ai's common stock on an as-converted basis, creating significant dilution and change-of-control implications for existing stockholders.

• · Transaction consideration was all-stock: Dot Ai common stock and Series C Convertible Preferred Stock at a $6.00 reference price.
• · Series C Preferred conversion requires Dot Ai stockholder approval to the extent required by Nasdaq rules; parties agreed to use reasonable best efforts to obtain approval by January 31, 2027, but approval was not a closing condition.
• · Envoy's $12.5M convertible note converts into Dot Ai common stock only upon stockholder approval and effectiveness of a resale registration statement, subject to certain exceptions.
• · Senior secured debt was settled and new working-capital financing completed in September 2026, preceding the closing.
• · The Company will submit evidence of Nasdaq compliance to the Nasdaq Hearings Panel; continued listing remains subject to the Panel's confirmation.
• · Transaction was approved by a Special Committee of independent directors and the Board of Directors.
• · Filing discloses a planned proxy statement with the SEC; record date to be set by the Board before mailing.

13-10-2026

Hubtown Limited, through its subsidiary Rare Townships Private Limited (RTPL), subscribed to 10,85,543 Class A equity shares at an issue price of ₹30 per share (face value ₹10, premium ₹20) for a total consideration of ₹3,25,66,290 under a rights issue residual entitlement. Hubtown's holding in RTPL rises from 74.65% to 75.24% of Class A equity share capital. RTPL reported turnover of Rs.9802.79 Lakh for FY2025-26, compared with Rs.40.45 Lakh in FY2024-25 and Rs.63.27 Lakh in FY2023-24.

• · Transaction is a related party transaction because RTPL is a subsidiary; the filing states it was conducted at arm's length, and promoters and promoter group hold interests to the extent of their shareholding in RTPL.
• · Allotment date is October 12, 2026, per Annexure A, while the disclosure letter is dated October 13, 2026.
• · No governmental or regulatory approvals were stated as required for the transaction.
• · Transaction was an internal capital infusion within the group and does not involve a change in control or acquisition of a new entity.
• · The filing reports a turnover figure of Rs.9802.79 Lakh for FY2025-26 that is about 242 times the prior-year figure, a sharp jump the filing does not explain.
• · The company incorporation date is given as June 052000, which appears to contain a typographical error.

13-10-2026

Alaunos Therapeutics (TCRT) disclosed, via an investor transaction and corporate overview presentation dated October 2026, its stock-for-stock acquisition of Velaris Therapeutics, Inc., with all Velaris equity exchanged for Alaunos common stock and non-voting Series C convertible preferred stock at a deal price of $1.4357 per common share. The transaction is paired with a concurrent $350 million private placement led by Fairmount, with proceeds intended to advance the Velaris pipeline toward proof-of-concept data and initial regulatory filings and to provide cash runway into 2029. The Velaris pipeline is entirely preclinical, with no clinical trials initiated, so the transaction carries substantial development and execution risk alongside its upside narrative.

• · Velaris is preclinical-stage with no clinical trials initiated; the presentation states no Company product candidate has been evaluated in humans
• · Pipeline milestones include IND or CTA filings for VLR199 and VLR360 in 2H27, VLR247 in 1H28, clinical start in 2027, and proof-of-concept data in 2028
• · Management risks flagged include reliance on an acting management team serving in an interim capacity, with transition to permanent roles pending
• · Dependence on Paragon Laboratories, the ninth company launched from Paragon assets, for discovery, research, manufacturing and development
• · Risk that the financing may not close on anticipated terms, and that the company will need substantial additional capital
• · No head-to-head trials exist between VLR199 and Winrevair; cross-study comparisons are not valid
• · Competitive pressure from companies developing ActRII-Fc and anti-PDGF-B therapies

13-10-2026

Info Edge (India) Limited's Board approved investments of about Rs. 100 crore each in two of its wholly owned subsidiaries: Startup Internet Services Limited (SISL) and Startup Investments (Holding) Limited (SIHL). For each, an initial tranche has been agreed (Rs. 20 crore for SISL and Rs. 25 crore for SIHL), with the balance (Rs. 80 crore and Rs. 75 crore respectively) to be infused in tranches within 1 year depending on future fund requirements. Both subsidiaries will remain wholly owned, and both had nil reported turnover over FY2023-24 to FY2025-26, so these are capital infusions into subsidiaries rather than acquisitions of new businesses.

• · SISL's FY2025-26 PAT was Rs. 1.77 crore and SIHL's was a loss of Rs. (0.02) crore, with SIHL net worth of Rs. 203.31 crore against SISL's Rs. 5.45 crore
• · Both subsidiaries reported nil turnover for FY2023-24 through FY2025-26
• · Transactions are described as arm's length, with no promoter, promoter group or group company interest, and no governmental or regulatory approvals required
• · Filing references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

13-10-2026

Starry Sea Acquisition Corp (SSEAR), a Cayman Islands SPAC, postponed its extraordinary general meeting from October 9, 2026 to October 19, 2026 to allow more time to engage with shareholders. Based on the redemption tabulation as of October 7, 2026, 4,281,993 public shares were submitted for redemption, leaving 1,468,007 public shares outstanding, and the company is seeking to reverse redemption requests on about 350,174 shares to reach at least 1,818,181 outstanding shares so the $60,000 monthly extension cap does not reduce the per-share contribution.

• · Filed under Item 7.01 (Regulation FD) and Item 8.01 (Other Events); the company furnished this as soliciting material under Rule 14a-12, tied to the upcoming shareholder vote
• · Per-share extension contribution is $0.033, and at the current 1,468,007 public shares the implied monthly contribution would be well below the $60,000 cap, which is why the company is pursuing reversals
• · The original redemption deadline was October 7, 2026, and the meeting was rescheduled from 10:00 a.m. to 9:00 a.m. Eastern Time on October 19, 2026

13-10-2026

Eureka Acquisition Corp, a SPAC, issued a promissory note dated October 7, 2026 for US$8,253.03 to Marine Thinking Inc., payable upon the earlier of a business combination or the expiry of the company's term. The note is non-interest-bearing, convertible at the payee's option into private units priced at $10.00 each, and carries standard default and cross-default provisions. This is an extension-related financing to fund the SPAC's operating costs, with no completed acquisition disclosed in the filing.

• · Principal is repayable on the earlier of a Business Combination or expiry of the company's term; prepayment is permitted without penalty.
• · Payee may convert the note into private units by giving notice at least two business days before a Business Combination closes.
• · Principal is non-recourse to the Trust Account: the payee waives claims to trust funds, and if no Business Combination occurs, repayment comes only from non-trust assets.
• · Overdue principal more than ten business days past maturity is an Event of Default; the payee may accelerate on payment default or breach of obligations.
• · Note references Registration Statement File No. 333-277780 and is not registered under the Securities Act (acquired for investment only).

13-10-2026

Tayo Rolls Limited, a corporate debtor under the Insolvency and Bankruptcy Code, 2016, has been acquired by Jharkhand Bijli Vitran Limited (JBVNL) via a resolution plan approved by the NCLT Kolkata on December 17, 2024. The implementation of the resolution plan has been stayed by the NCLAT, New Delhi, and a deadlock between the Successful Resolution Applicant (SRA) and the Resolution Professional (RP) has left the erstwhile Compliance Officer unable to meet quarterly and annual statutory filings, which he has requested be exempted from liability.

• · NCLT Kolkata approved the resolution plan on December 17, 2024; NCLAT New Delhi has stayed its implementation
• · Resolution Professional appointed by the Adjudicating Authority via order dated October 30, 2019
• · Filing relates to quarterly compliance for the quarter ended June 30, 2026
• · Compliance Officer requests exemption of erstwhile key managerial personnel from statutory liability
• · Company's official email IDs and website are reported as inoperative
• · Company is listed on BSE under stock code 504961 and CIN L27105JH1968PLC000882 (as shown in letterhead)

13-10-2026

13-10-2026

Maithan Alloys Limited disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015 that it acquired 765,000 equity shares of HFCL Limited through the stock exchange on October 12, 2026, for a total cost of Rs. 20.14 Crore, triggering a threshold disclosure requirement. The company states the investment is made for long-term/short-term investment benefits and that it does not intend to acquire control of HFCL's management. HFCL reported FY 2025-26 turnover of Rs. 4528 Crore, PAT of Rs. 253 Crore, and net worth of Rs. 4727 Crore.

• · Acquisition event occurred at 3:30 P.M. on October 12, 2026; company became aware of details on October 13, 2026 at 10:03 A.M.
• · Target entity is not a related party; no promoter or group company holds an interest in HFCL Limited.
• · Transaction was conducted at arm's length and involved cash consideration.
• · No governmental or regulatory approval was required for the acquisition.
• · HFCL Limited's turnover grew approximately 19% YoY from Rs. 3795 Crore in FY 2024-25 to Rs. 4528 Crore in FY 2025-26.

13-10-2026

Quadrant Televentures Limited, currently under Corporate Insolvency Resolution Process (CIRP) following an NCLT order dated September 2, 2025, disclosed the outcome of its 16th Committee of Creditors (CoC) meeting, held via e-voting. The single resolution put to vote, ratifying the appointment of senior counsel and professional fees for representing the Resolution Professional in the interlocutory application for approval of the resolution plan, was approved by 95.6% against a 51% required threshold. The filing is procedural and does not disclose any financial figures or change in the company's operating position.

• · The 16th CoC meeting was originally convened for September 28, 2026, per a September 23, 2026 intimation, and voting was conducted under Regulation 26 of the CIRP Regulations, 2016.
• · Disclosure was made under Regulation 30 read with Clause 16(f) and (g) of Para A of Part A of Schedule III of the SEBI LODR Regulations, 2015, as a post-facto intimation.
• · The company operates under a Resolution Professional, and the CoC approved funding for senior counsel representing the RP in the resolution plan approval application.

13-10-2026

Authum Investment & Infrastructure Limited, as part of a consortium with Inox Neo Energies Limited (Lead Member), has been informed by the Implementation and Monitoring Committee of Wind World (India) Limited that the consortium has discharged its obligations under the February 13, 2026 Resolution Plan (as amended by an addendum dated May 20, 2026). The IMC has declared October 08, 2026 as the Implementation Date for the acquisition of Wind World (India) Limited through the insolvency resolution process.

• · Prior intimations regarding this matter were made on February 20, 2026, July 28, 2026, and October 10, 2026
• · Consortium members are Inox Neo Energies Limited (Lead Member) and Authum Investment & Infrastructure Limited
• · Wind World (India) Limited CIN: U31200DD2003PLC003236
• · IMC communicated the implementation confirmation to the company on October 12, 2026

13-10-2026

Jubilant Ingrevia Limited has informed the exchanges that its proposed wholly-owned subsidiary, Jubilant Advanced Electronics Limited, was incorporated on October 12, 2026, following approval from the Registrar of Companies. This follows the company's October 1, 2026 Regulation 30 disclosure regarding the proposed incorporation, and all other particulars from that letter remain unchanged.

• · Event date and time of occurrence: October 12, 2026 at 7:52 P.M. (IST)
• · Scrip Code: 543271; Trading Symbol: JUBLINGREA
• · Subsidiary is a wholly-owned subsidiary (WOS) of Jubilant Ingrevia Limited

13-10-2026

IX Acquisition Corp. convened and adjourned its extraordinary general meeting in lieu of an annual general meeting on October 7, 2026, with shareholders approving the Fifth Extension Amendment Proposal and the Auditor Ratification Proposal. Quorum was met with approximately 66.17% of issued and outstanding ordinary shares present or represented. In connection with the vote, 435,000 shares were tendered for redemption.

• · The Meeting was adjourned to October 9, 2026 at 12:00 p.m. Eastern Time (the filing text references 2025 in one place, which appears to be a typo)
• · The Proxy Statement was filed with the SEC and first mailed to shareholders on or about September 25, 2026
• · Only 13 votes were cast against the Fifth Extension Amendment Proposal, indicating near-unanimous support

13-10-2026

ClearOne, Inc. (NASDAQ: CLRO) received a Nasdaq Staff determination letter on October 8, 2026 that it failed to satisfy the $2.5 million minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1), after not completing remedial actions in its compliance plan submitted May 22, 2026. Nasdaq has determined to delist the company's common stock, but the company intends to request a hearing before a Nasdaq Hearings Panel by October 15, 2026, which would automatically stay suspension; absent a timely hearing request, trading would be suspended at the open on October 19, 2026. The filing contains no quantitative financial results and is negative in tone with significant uncertainty about the outcome.

• · Nasdaq initially notified the company on April 7, 2026 of non-compliance with Listing Rule 5550(b); a compliance plan deadline of May 22, 2026 applied, and Nasdaq granted an exception through October 5, 2026
• · Hearing request deadline is October 15, 2026; trading suspension would occur at the open on October 19, 2026 if no hearing is requested
• · The company states there is no assurance Nasdaq will grant a hearing or that it will regain compliance
• · The company's FY2025 Form 10-K was filed March 31, 2026 and is referenced for risk factors

13-10-2026

Quetta Acquisition Corporation (QETAR), a Delaware SPAC, held a special meeting on October 9, 2026, where stockholders approved an extension amendment pushing its deadline to complete an initial business combination from October 10, 2026 to October 10, 2027 (extendable monthly, with a $5,000 trust deposit per extension). Holders of 1,550,843 shares redeemed for an aggregate of approximately $18.4 million, leaving only 149,860 shares outstanding. The vote passed with 2,486,760 votes for and 525,980 against.

• · Roughly 96% of the 3,747,748 shares outstanding did not remain in the company after redemptions, leaving 149,860 shares
• · Extension permits the deadline to be moved up to a date set by the Board of Directors, not only through the full twelve-month period
• · Company intends to file the charter amendment with the Delaware Secretary of State

13-10-2026

Rising Dragon Acquisition Corp. (RDACU), a Cayman Islands SPAC, issued a non-interest-bearing promissory note dated August 15, 2026 for US$55,637.41 to sponsor-affiliate SZG Limited, with proceeds to be deposited into the Trust Account to extend the deadline for completing its business combination. The note is payable at the closing of the business combination, is convertible into private units at US$10.00 per unit, and is tied to a merger agreement dated January 27, 2025. No positive or negative financial performance metrics are reported in this filing, which is a financing and deal-structuring disclosure.

• · Note is payable on the date of the initial business combination; it terminates without amounts due if the merger agreement is terminated under section 13.2(a) by the Maker, or if the business combination fails to close for reasons not attributable to the Maker or the agreement is mutually terminated.
• · Payee may convert the note into private units by giving notice at least five business days before closing; units issued equal principal divided by US$10.00, with cash paid for any fractional units.
• · Events of default include failure to pay principal within five business days of due date, voluntary bankruptcy or insolvency actions, and involuntary bankruptcy orders unstayed for 60 consecutive days.
• · Note is governed by New York law with exclusive jurisdiction in New York courts; Payee waives any claim against Trust Account funds, except for certain claims against assets held outside the trust.
• · Merger agreement referenced is dated January 27, 2025; the IPO prospectus is dated October 10, 2024.

13-10-2026

Mr. Prafful Agarwal and Mrs. Anupam Gupta (Acquirers) have announced an open offer under SEBI (SAST) Regulations 2011 to acquire up to 43,58,163 fully paid-up equity shares of Frontier Capital Limited, representing 26.00% of its total equity and voting share capital on a fully diluted basis, at ₹10.20 per share in cash. Srujan Alpha Capital Advisors LLP has been appointed as Manager to the Open Offer, and the Public Announcement dated October 13, 2026 was filed with SEBI and the target company.

• · Acquirers are acquiring under Regulations 3(1) and 4 of the SEBI (SAST) Regulations, 2011, indicating a substantial acquisition triggering a mandatory open offer
• · Srujan Alpha Capital Advisors LLP appointed as Manager to the Open Offer under Regulation 12(1) and Regulation 14(1)
• · Public Announcement submitted to SEBI and the target company; BSE requested to upload it on its website

13-10-2026

Share India Securities Limited intimated the stock exchanges that the Hon'ble NCLT, Ahmedabad Bench-I, by a rectification order pronounced on October 12, 2026, changed the Appointed Date of the Scheme of Amalgamation of Silverleaf Capital Services Private Limited (Transferor Company) with Share India from October 1, 2023 to April 1, 2026. The rectification was sought on the basis of revised Board resolutions dated June 24, 2026, and the Regional Director has raised no objection. The certified copy of the order is still awaited, and the Scheme becomes effective only after the steps in the approved Scheme are completed.

• · Original Appointed Date was October 1, 2023; rectified Appointed Date is April 1, 2026
• · NCLT original sanction order was dated August 20, 2026; rectification order pronounced October 12, 2026
• · Regional Director raised an objection on June 19, 2026 to the original Appointed Date; the RD later filed a no-objection reply on October 7, 2026
• · Revised Scheme was placed on record with reply affidavit dated July 20, 2026
• · Board resolutions approving the change in Appointed Date were passed on June 24, 2026
• · Rectification order was published on the NCLT website at 4:39 p.m. on October 12, 2026
• · Certified copy of the rectification order is awaited; company will update exchanges once the Scheme becomes effective
• · Registry directed to send the order to the Regional Director, ROC, BSE and NSE within seven days

13-10-2026

The Hi-Tech Gears Limited disclosed that the Hon'ble NCLAT could not hear its insolvency-related appeal on October 07, 2026, and has adjourned the matter to November 06, 2026. The Tribunal has directed the continuation of the interim stay on the Corporate Insolvency Resolution Process (CIRP) granted on September 03, 2024, leaving the CIRP on hold pending the next hearing.

• · NCLAT Company Appeal (AT) (Ins) No. 1734 of 2024 and I.A. No. 2735 of 2025 was not heard on October 07, 2026 due to paucity of time.
• · The next hearing is scheduled for November 06, 2026.
• · The interim stay on CIRP was originally granted by NCLAT on September 03, 2024, and has now been continued.
• · The NCLAT order was uploaded to its website on October 13, 2026.
• · The filing follows an earlier intimation dated October 06, 2026 on the same subject.

13-10-2026

Horizon Space Acquisition I Corp. (HSPO), a SPAC, announced a definitive business combination agreement with ArcheNova Biotech Corp., a clinical-stage biopharmaceutical company developing MSC-derived exosome therapeutics. Upon closing, a newly formed Cayman Islands entity (PubCo) will list on Nasdaq, with HSPO and ArcheNova becoming wholly-owned subsidiaries via a two-step merger, expected to close in Q1 2027 subject to regulatory and shareholder approvals. The filing contains no reported financial results, valuation, or transaction consideration amounts, and closing is not assured.

• · Transaction structured as two sequential mergers: ArcheNova International merges into HSPO (First Merger), then ArcheNova Global merges into ArcheNova (Second Merger), both as wholly-owned PubCo subsidiaries
• · HSPO warrants will be assumed by PubCo and converted into warrants to purchase PubCo Ordinary Shares on substantially the same terms
• · Both boards unanimously approved the Proposed Transactions
• · Form F-4 registration statement with proxy statement/prospectus to be filed with the SEC
• · Closing risk factors include the amount of cash remaining after HSPO shareholder redemptions
• · HSPO's most recent Form 10-K was filed April 15, 2026 for fiscal year ended December 31, 2025
• · HSPO trades OTC under symbol HSPOF; PubCo expects Nasdaq listing

13-10-2026

Ambuja Cements Limited disclosed that, following the Hon'ble National Company Law Tribunal (NCLT) Ahmedabad Bench order dated October 8, 2026, the hearing on the Joint Company Petition for the amalgamation of ACC Limited into Ambuja Cements has been fixed for November 19, 2026. The notice of hearing was published on October 13, 2026 in the Indian Express (all editions) and the Financial Express (Ahmedabad edition, Gujarati translation). The filing is a procedural compliance disclosure with no stated financial figures on the merger itself.

• · NCLT Ahmedabad Bench hearing on the Joint Petition under Sections 230 to 232 fixed for November 19, 2026
• · Notice published in English in Indian Express (all editions) and Gujarati in Financial Express (Ahmedabad edition) on October 13, 2026
• · Disclosure also available at www.ambujacement.com

13-10-2026

SKIL Infrastructure Limited, which is under Corporate Insolvency Resolution Process (CIRP) per a February 1, 2024 order of the Hon'ble NCLT Mumbai, disclosed the outcome of its Thirteenth Committee of Creditors (COC) meeting held virtually on October 13, 2026, from 11:00 AM to 1:30 PM. The filing was submitted by Resolution Professional Purusottam Behera under Regulation 30 and Schedule III of the SEBI LODR Regulations, 2015. The filing contains no financial figures, resolutions, or decisions taken at the meeting.

• · CIN: L36911MH1983PLC178299; NSE Symbol: SKIL; BSE Scrip Code: 539861
• · CIRP order dated February 1, 2024 by Hon'ble NCLT Mumbai
• · Resolution Professional registration: IBBI/IPA-002/IP-N00940/2019-20/12993; AFA valid till December 31, 2026
• · Meeting held through audio-visual means in virtual mode, 11:00 AM to 1:30 PM

13-10-2026

Medtronic plc filed Amendment No. 3 to its Schedule TO on October 13, 2026, reporting preliminary results of its issuer exchange offer for shares of MiniMed Group, Inc. The offer expired October 9, 2026 and was oversubscribed, with 298,024,452 Medtronic Ordinary Shares validly tendered against 55,032,401 shares Medtronic intends to accept, implying an estimated preliminary proration factor of approximately 18.3% for shares subject to proration. Medtronic will exchange 55,032,401 of its ordinary shares for 252,813,348 MiniMed common shares, subject to a final proration factor pending the guaranteed delivery period.

• · Exchange offer expired at 12:00 midnight New York City time on October 9, 2026
• · Proration applies because the offer was oversubscribed; odd-lot holders who tendered all shares were not prorated
• · Estimated preliminary proration factor is subject to change based on guaranteed delivery tenders, with the final factor expected promptly after the guaranteed delivery period ends
• · Unaccepted Medtronic shares will be returned in book-entry form after the final proration factor is determined
• · Registration on Form S-4 (No. 333-298914) was filed by MiniMed to register the MiniMed shares offered
• · Press release announcing preliminary results issued October 12, 2026 (Exhibit (a)(4)(xxxiv))

13-10-2026

ACC Limited disclosed that the NCLT Ahmedabad Bench has fixed November 19, 2026 as the hearing date for the Joint Company Petition seeking approval of the Scheme of Amalgamation of ACC Limited with Ambuja Cements Limited, following a tribunal order dated October 8, 2026. Notice of the hearing was published on October 13, 2026 in the Indian Express (all editions) and in Gujarati in the Financial Express (Ahmedabad edition). The filing is a procedural update and contains no financial results or deal-value figures.

• · NCLT Ahmedabad Bench hearing on the Joint Company Petition (Sections 230 to 232) is scheduled for November 19, 2026
• · Tribunal order directing the hearing was dated October 8, 2026
• · Notice published in English in Indian Express (all editions) and in Gujarati in Financial Express (Ahmedabad edition) on October 13, 2026
• · Disclosure also posted on the company website at www.acclimited.com

13-10-2026

ACME Solar Holdings Limited has disclosed under Regulation 30 of the SEBI Listing Regulations that it incorporated two wholly owned subsidiaries, Amshuman Renewables Private Limited and Urjita Powertech Private Limited, both incorporated on October 13, 2026 with registered offices in Gurugram, Haryana. The company subscribed 100% of the initial paid-up share capital in cash, at Rs. 1,00,000 for 10,000 equity shares of Rs. 10 face value each, for each entity. The subsidiaries are established to develop, establish and operate power generation and renewable energy projects, and the filing states no governmental or regulatory approvals were required for incorporation.

• · Filing made under Regulation 30 of SEBI LODR, referencing SEBI Master Circular Ref. No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
• · Company CIN: L40106HR2015PLC102129; scrip code 544283 (BSE), symbol ACMESOLAR
• · No governmental or regulatory approvals were required for the incorporations
• · Subsidiaries are not an acquisition of an existing business; they are newly formed entities, so this is not an Acquisition event

13-10-2026

SEBI has issued an adjudication order following an inspection of IIFL Capital Services Limited, dated October 13, 2026. The filing text provided contains only the title and metadata, so the nature of the findings, any penalty amount, and the specific violations cited cannot be determined from the content available. The order represents an enforcement action by the securities regulator against the company.

• · Order is an Adjudication Order issued by SEBI's Adjudicating Officer (Orders of AO category)
• · Order arises from an inspection of the company, indicating a prior regulatory examination
• · Full order text was not provided; penalty amounts, violations, and directions are unverified

13-10-2026

Newton Golf Company (Nasdaq: NWTG) received a Nasdaq Staff Determination on October 6, 2026, finding it has not demonstrated compliance with the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1), following a deficiency letter first received April 6, 2026. Unless the company requests an appeal by October 13, 2026, trading of its common stock will be suspended at the opening of business on October 15, 2026, and a Form 25-NSE will be filed to remove its securities from Nasdaq. The company intends to request a Nasdaq Hearings Panel hearing, which would stay the suspension and delisting pending the Panel's decision.

• · Deadline to request appeal of Staff Determination: October 13, 2026
• · Scheduled trading suspension if no appeal: opening of business October 15, 2026
• · Company's stock ticker: NWTG; Nasdaq Listing Rule 5550(b)(1) cited
• · A timely hearing request would stay both the trading suspension and the Form 25-NSE filing pending the Panel's decision
• · Company is an emerging growth company; the filing notes no assurance the Panel will grant continued listing or that compliance will be regained

13-10-2026

Sun Granite Export Ltd. has filed an intimation with BSE under SEBI LODR Regulation 30 disclosing the List of Creditors as on 13 October 2026, as required under IBBI CIRP regulation 13(2)(ca) during its Corporate Insolvency Resolution Process. The company does not currently maintain a functional website, so the list is submitted to the exchange instead, and the list remains subject to revision as the process continues.

• · Scrip Code on BSE: 531013; CIN: L14102OR1991PLC002834
• · Resolution Professional's AFA valid up to 31 December 2026
• · Company does not presently maintain a functional website; filing made to the exchange in lieu of website disclosure

13-10-2026

Talwalkars Better Value Fitness Limited has intimated to BSE and NSE that 26 October 2026 is the record date for a capital reduction approved under an NCLT (National Company Law Tribunal) order. The filing is a Regulation 42 record-date intimation signed by Managing Director Shilpa Singh, and it notes that the related meeting ran from 5:00 PM to 5:30 PM. No financial amounts, percentages, or share counts are disclosed in the filing.

• · Record date: 26 October 2026 (Monday), set under Regulation 42 of SEBI (LODR) Regulations, 2015
• · Stated purpose: capital reduction as directed by an NCLT order
• · The related meeting commenced at 5:00 PM and concluded at 5:30 PM on 13 October 2026
• · Scrip code BSE 533200; NSE symbol TALWALKARS

13-10-2026

Dr. Lal PathLabs Ltd. disclosed that its wholly owned subsidiary PathLabs Unifiers Private Limited (PUPL) acquired the remaining 30% equity stake in Centrapath Labs Private Limited (CPL) on October 13, 2026, making CPL a wholly owned subsidiary of PUPL. The acquisition was paid in cash at INR 1,608.352 per share, is not a related party transaction, and was completed with no governmental or regulatory approvals required. CPL reported turnover of 20.5 Crore in FY 2026, down from 23.7 Crore in FY 2025 (a decline of about 13.5%), though up from 20.8 Crore in FY 2024 on a two-year basis, which is a flat-to-slightly-lower trend.

• · The acquisition follows an earlier intimation dated October 12, 2026 regarding further investment in PUPL
• · CPL was incorporated on July 23, 2019 in Indore, Madhya Pradesh
• · Transaction is not a related party transaction and no promoter or promoter group interest is disclosed
• · No governmental or regulatory approvals were required; the transaction is marked as completed

13-10-2026

Orient Cement Limited disclosed that the NCLT Ahmedabad Bench has fixed November 19, 2026 as the hearing date for the Joint Company Petition under Sections 230 to 232 concerning the proposed Scheme of Amalgamation of Orient Cement Limited (Transferor Company) with Ambuja Cements Limited (Transferee Company). The notice of hearing was published on October 13, 2026 in the Indian Express (all editions, English) and the Financial Express (Ahmedabad edition, Gujarati translation). The filing contains no financial results or amounts attributable to Orient Cement itself.

• · Tribunal order governing the petition is dated October 8, 2026
• · Joint Company Petition filed under Sections 230 to 232 of the Companies Act
• · Hearing scheduled for Thursday, November 19, 2026 before the NCLT Ahmedabad Bench
• · Notice published in English in Indian Express (all editions) and Gujarati in Financial Express (Ahmedabad edition)
• · Disclosure is a procedural notice; no regulatory action against the company is reported

13-10-2026

Parvati Sweetners and Power Ltd. issued a Regulation 30 update stating that its acquisition of a 51% equity stake in Vedshree Food Industries Private Limited is progressing after shareholder approval, with the company now obtaining government approvals. The company states the transaction is on track for completion within the stipulated timeline, though no financial terms or quantitative figures were disclosed in this update.

• · Acquisition was previously recommended by the Executive Committee, recommended by the Audit Committee, approved by the Board, and approved by shareholders at a General Meeting
• · Share Purchase Agreement (SPA) was executed under the earlier disclosure dated May 30, 2026
• · Remaining step is obtaining approvals from concerned government authorities before completion
• · No purchase consideration, valuation, or financial impact of the acquisition is disclosed in this update

13-10-2026

GTPL Hathway's Board approved the acquisition of the remaining 74% equity stake in its subsidiary DL GTPL Cabnet Private Limited for Rs 8,32,50,000 (Rs 83.25 Crore), making it a wholly owned subsidiary, with completion expected by October 31, 2026. For the quarter ended September 30, 2026, revenue from operations rose 16.0% YoY to Rs 7,975.74 million, but net profit fell sharply to a loss of Rs (13.47) million from a profit of Rs 52.49 million a year earlier, and standalone trade receivables more than doubled from Rs 4,190.88 million at March 31, 2026 to Rs 11,312.20 million.

• · Acquisition is for consolidation of business operations; no promoter/group company interest; transferors are related parties of DL GTPL on arm's length basis
• · No governmental or regulatory approvals required for the DL GTPL acquisition
• · Acquisition expected to complete by October 31, 2026
• · Quarter-on-quarter, revenue rose from Rs 6,877.25 million (June 30, 2026 quarter) to Rs 7,975.74 million, while the quarter's net result swung to a loss from a Rs 20.12 million profit
• · Operating expenses rose to Rs 6,366.13 million in the quarter from Rs 4,972.41 million a year earlier, and finance costs rose 54% YoY to Rs 112.79 million
• · Standalone operating cash flow for H1 FY27 was Rs 1,229.18 million, but net cash used in investing was Rs (992.12) million and net cash from financing was Rs (348.63) million, leaving cash down to Rs 47.17 million
• · Auditor's review report on the standalone results carries no modification; Note 3 DoT demand is a contingent liability with no provision recognized, and the company asserts it has good merit grounds to defend

13-10-2026

Nasdaq Stock Market LLC filed a Form 25-NSE notice on October 13, 2026 for Bone Biologics Corp (BBLGW), the company's warrants, to remove them from listing and registration on Nasdaq under 17 CFR 240.12d2-2(a)(2). The filing is an exchange-initiated delisting of the warrant class, with the company's Burlington, MA address and a signed date of October 12, 2026. No monetary amounts, financial results, or operating metrics are disclosed in the filing.

• · Filing cites 17 CFR 240.12d2-2(a)(2), the provision allowing an exchange to withdraw registration of a security, and it covers only the warrant class, not the company's common stock.
• · SEC file number 001-40899; company CIK 0001419554; company fiscal year end December 31.

13-10-2026

Advent Hotels International Limited's Board approved a Share Purchase Agreement to acquire the remaining 25% equity stake in its 75% subsidiary BD&P Hotels (India) Private Limited for a total consideration of Rs. 40,00,00,000 (Rs. 40 Cr), making it a wholly owned subsidiary upon completion, expected by June 30, 2027. BD&P Hotels' turnover rose 3.9% to Rs. 102,36,75,000 in FY 2025-26 from Rs. 98,52,74,000 in FY 2024-25, though growth was more modest than the approximately 23.8% increase recorded in FY 2024-25 versus FY 2023-24.

• · Implied valuation for the 25% stake is approximately Rs. 40 Cr, the entire consideration is to be paid via banking channels
• · BD&P Hotels owns a 1.26-acre property at Andheri (East), Mumbai and operates a Hilton-branded hotel with 171 keys, banquets and conference facilities
• · No governmental or regulatory approvals are required for the acquisition
• · The selling shareholders are not related parties, so the transaction is not a related party transaction and promoters have no interest in BD&P Hotels beyond their existing shareholding
• · Completion timeline is on or before June 30, 2027, unless mutually extended by the parties

13-10-2026

The New York Stock Exchange filed a Form 25-NSE with the SEC to remove Allurion Technologies, Inc.'s common stock and warrants from listing and registration, effective October 26, 2026. The delisting follows the company falling below the NYSE's continued listing standard requiring an average global market capitalization of at least $15,000,000 over 30 consecutive trading days (Section 802.01B). Trading was suspended after the close on March 6, 2026, and the company withdrew its appeal on July 2, 2026.

• · Delisting effective date is October 26, 2026, under Rule 12d2-2(b)
• · Company was notified by letter and a press release was issued on March 6, 2026
• · Company requested an appeal before the NYSE Board Committee on March 12, 2026, then withdrew it on July 2, 2026
• · Filing relates to the company's SEC file number 001-41767

13-10-2026

The New York Stock Exchange notified the SEC of its intention to delist SilverBox Corp IV's Class A Ordinary Shares, Units, and Redeemable Warrants (SBXD-WT) effective October 26, 2026, under Rule 12d2-2(b). The removal follows the company falling below the NYSE's continued listing standard of maintaining an average aggregate global market capitalization of at least $40 million for publicly-held shares over 30 consecutive trading days; trading was suspended after the close on September 25, 2026, and the company did not appeal within the ten-business-day window.

• · Trading in the securities was suspended at the close of market on September 25, 2026, ahead of the scheduled removal date
• · The delisting is effective October 26, 2026, and the filing was made under SEC Rule 12d2-2(b)
• · The company did not request an appeal to the NYSE Committee of the Board of Directors, so the delisting determination stands

13-10-2026

Siti Networks Limited disclosed that the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, by order dated September 28, 2026 (received October 12, 2026), appointed Mr. Trupalkumar Patel as Resolution Professional of the Company. The filing is a Regulation 30 disclosure under SEBI Listing Regulations and attaches the NCLT order as Annexure A. No financial figures are disclosed in the filing.

• · Resolution Professional registration reference: IBBI/IPA-001/IP-P01186/2018-19/11907
• · NCLT order dated September 28, 2026 was received by the company on October 12, 2026, a one-day gap before disclosure
• · Disclosure made to both BSE (Scrip Code 532795) and NSE (Symbol SITINET)

13-10-2026

Hero Motors Ltd reported standalone and consolidated unaudited results for the quarter ended June 30, 2026, with consolidated revenue from operations of ₹31,932.31 lakhs (down 0.99% QoQ from ₹32,252.55 lakhs, but up 24.87% YoY from ₹25,574.27 lakhs) and consolidated net profit of ₹957.10 lakhs, down 32.60% QoQ from ₹1,419.74 lakhs but up 146.91% YoY from ₹387.60 lakhs. Results were approved on October 13, 2026, following the company's IPO (₹60,000 lakhs fresh issue plus ₹40,000 lakhs offer for sale at ₹84 per share), with listing on NSE and BSE on September 23, 2026. Sequential profitability weakened while year-on-year profitability and top-line growth were strong.

• · Consolidated profit before tax of ₹1,558.71 lakhs fell 27.30% QoQ from ₹2,143.85 lakhs, though it rose 141.07% YoY from ₹646.29 lakhs.
• · Alloy and Metallics segment reported a loss of ₹255.13 lakhs in the quarter, narrowing from a ₹625.26 lakh loss in the prior quarter but still negative.
• · Consolidated employee benefits expense rose 7.49% QoQ to ₹4,438.83 lakhs from ₹4,129.23 lakhs.
• · Consolidated net worth attributable to equity holders is reflected in other equity of ₹48,101.34 lakhs; paid-up share capital stood at ₹35,928.75 lakhs.
• · Standalone quarterly revenue from operations was ₹27,819.65 lakhs versus ₹21,446.92 lakhs a year earlier, and standalone profit for the period was ₹2,340.48 lakhs.
• · Subsequent to quarter end, 2,09,71,941 CCPS were converted into equity shares, and 951,528 ESOPs were exercised by the MD and CEO at ₹10 per option.